Biocon has built its credibility as an innovation-led enterprise through a track record of IP value creation in discovery, research and development
Biocon, a biopharmaceuticals company, has been recognised for its world class Intellectual Property (IP) management and IP value creation in the Asian region by IP Business Congress Asia (IPBC Asia) and has made its debut on the Asia IP Elite 2016 list.
Biocon has built its credibility as an innovation-led enterprise through a track record of intellectual property value creation in discovery, research and development. The company release stated that it has an IP portfolio of 1250 patent applications out of which 990 are granted patents and 820 trademark applications consisting of 460 registered trademarks.
The list comprises 62 companies such as Alibaba, Baidu, Canon, Fujifilm, Samsung Electronics, LG Electronics, Acer and ASUStek from nine countries in Asia which have been recognised for excellence in IP and best in-class in-house IP functions.
The companies selected as the Asia IP Elite were honoured at the latest edition of the IP Business Congress Asia, held in Shanghai, which addresses IP value creation to be held in Asia. The Congress was attended by over 400 senior IP decision makers from major IP owning companies.
EP News Bureau